NASDAQ : ADVB
Advanced Biomed Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 2.3 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.80M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.43M |
| Enterprise Value | 4.12M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 18, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.65M |
| Shares Outstanding | 1.65M |
| Shares Change (YoY) | +22.06% |
| Shares Change (QoQ) | +21.79% |
| Owned by Insiders (%) | 40.30% |
| Owned by Institutions (%) | 0.06% |
| Float | 986,283 |
Ratios
| Measure | Value |
|---|
| PE Ratio | 0.39 |
| Forward PE | n/a |
| PS Ratio | 26.86 |
| Forward PS | n/a |
| PB Ratio | 0.28 |
| P/TBV Ratio | 0.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 0.62 |
| EV / Sales | 32.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 9.33 |
| Quick Ratio | 9.33 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -888.73 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -79.49% |
| Return on Assets (ROA) | -21.28% |
| Return on Invested Capital (ROIC) | -46.29% |
| Return on Capital Employed (ROCE) | -50.78% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $10,636 |
| Profits Per Employee | $556,423 |
| Employee Count | 12 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -1,205 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -78.41% |
| 50-Day Moving Average | 6.40 |
| 200-Day Moving Average | 5.90 |
| Relative Strength Index (RSI) | 19.26 |
| Average Volume (20 Days) | 37,811 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9,747 |
| Short Previous Month | 18,897 |
| Short % of Shares Out | 0.59% |
| Short % of Float | 0.99% |
| Short Ratio (days to cover) | 0.50 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 127,637 |
| Gross Profit | 127,637 |
| Operating Income | -6.23M |
| Pretax Income | -6.26M |
| Net Income | 6.68M |
| EBITDA | -6.17M |
| EBIT | -6.23M |
| Earnings Per Share (EPS) | $5.33 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 385,535 |
| Total Debt | 1.08M |
| Net Cash | -692,680 |
| Net Cash Per Share | -$0.42 |
| Equity (Book Value) | 12.28M |
| Book Value Per Share | 7.43 |
| Working Capital | 12.28M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -1.95M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 59,281 |
| Net Borrowing | 1.08M |
| Free Cash Flow | -1.95M |
| FCF Per Share | -$1.18 |
Margins
| Measure | Value |
|---|
| Gross Margin | 100.00% |
| Operating Margin | -4,883.80% |
| Pretax Margin | -4,906.48% |
| Profit Margin | 5,231.30% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -22.06% |
| Shareholder Yield | -22.06% |
| Earnings Yield | 256.87% |
| FCF Yield | -56.79% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 20, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.82 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |